11/17/2008
Boston, MA – Attorneys from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Boston and San Diego offices represented Genelabs Technologies, Inc. in a $57 million deal in which GlaxoSmithKline (GSK) will acquire the Redwood City, California company. The acquisition will strengthen GSK's effort to develop and deliver novel therapies against the hepatitis C virus.
Under the terms of the agreement, a subsidiary of GSK has commenced a tender offer to acquire all of the outstanding shares of Genelabs for $1.30 per share. Genelabs' board of directors has unanimously recommended that shareholders tender their shares in the offer. The deal is expected to close in December 2008.
Representing Genelabs Technologies were Mintz Levin corporate members Jonathan Kravetz and Megan Gates and associate Wendy Silverman, from the firm's Boston office. Corporate member Jeremy Glaser and associate Sebastian Lucier, of the firm's San Diego office, also assisted in the transaction.
Other recent transactions conducted by Mintz Levin attorneys include representing Cambridge, Massachusetts-based Vertex Pharmaceuticals Incorporated in a follow on financing which raised approximately $220 million.
Mintz Levin is an AmLaw 100 law firm with offices in the US and the UK. The firm has exceptional depth in a broad range of practice areas, but our clients recognize that what sets us apart from other law firms is our industry focus. By truly understanding business drivers and industry trends, we are able to provide our clients with more than just legal advice; we provide legal solutions to our clients' business issues. Since 1933, our lawyers have represented entrepreneurs, emerging growth companies, Fortune 500 companies, government agencies, not-for-profit organizations and leaders in primary industries that include Life Sciences/Biotechnology; Technology & Communications; Energy & Clean Technology; Financial Services & Insurance; Healthcare; Real Estate, Hospitality & Construction; and Retail & Consumer Products. Our practical knowledge combined with our industry expertise enables us to provide our clients with enterprise legal advice that gives their business a competitive advantage in the marketplace.